Assessment of the Effects of Anatoxin-a In Vitro: Cytotoxicity and Uptake

Cristina Plata-Calzado1, Ana I Prieto1, Ana M Cameán1

  • 1Area of Toxicology, Faculty of Pharmacy, Universidad de Sevilla, Profesor García González 2, 41012 Seville, Spain.

Toxins
|December 27, 2024
PubMed

Insights

Anatoxin-a (ATX-a) shows limited cytotoxicity across most cell types. However, immune and neuronal cells accumulate higher levels of this cyanotoxin, warranting further investigation into its toxic effects.

Area of Science:

  • Environmental Toxicology
  • Cyanotoxin Research
  • Cellular Toxicology

Background:

  • Anatoxin-a (ATX-a) is an understudied cyanotoxin with potential impacts beyond neurotoxicity.
  • Its widespread occurrence necessitates a better understanding of its toxicological profile.
  • Previous research has not fully elucidated ATX-a's effects on various organs and systems.

Purpose of the Study:

  • To evaluate the cytotoxicity of Anatoxin-a (ATX-a) in a diverse range of cell lines representing potential target organs.
  • To investigate the cellular uptake of ATX-a in different cell types.
  • To analyze gene expression related to cell death pathways following ATX-a exposure.

Main Methods:

  • Cytotoxicity assays were performed on N2a, SH-SY5Y, HepG2, Caco2, L5178Y Tk+/-, THP-1, and Jurkat cell lines.
  • Ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was used to quantify intracellular ATX-a.
  • Polymerase chain reaction (PCR) was employed to assess gene expression in THP-1 cells.

Main Results:

  • Limited cytotoxicity was observed, with only Jurkat and THP-1 cells showing reduced viability at 200 µg/mL ATX-a after 24 hours.
  • Immune system cells (THP-1, Jurkat) exhibited the highest intracellular ATX-a accumulation, followed by neuronal cells (N2a, SH-SY5Y).
  • No significant changes in cell death-related gene expression were detected in THP-1 cells under the tested conditions.

Conclusions:

  • Anatoxin-a demonstrates low cytotoxicity in most tested cell lines.
  • Immune and neuronal cells show higher ATX-a uptake, suggesting potential target organ specificity.
  • Further research into ATX-a's toxic effects and toxicokinetics is crucial for accurate risk assessment.